EXCRETION OF MECAMYLAMINE AFTER INTRAVENOUS AND ORAL ADMINISTRATION

被引:9
作者
ALLANBY, KD
TROUNCE, JR
机构
关键词
D O I
10.1136/bmj.2.5055.1219
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1219 / 1221
页数:3
相关论文
共 10 条
[1]   RENAL ELIMINATION OF 3-METHYLAMINOISOCAMPHANE HYDROCHLORIDE (MECAMYLAMINE) [J].
BAER, JE ;
PAULSON, SF ;
RUSSO, HF ;
BEYER, KH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1956, 186 (01) :180-186
[2]  
BRODIE BB, 1945, J BIOL CHEM, V158, P705
[3]  
DOYLE A E, 1955, Practitioner, V174, P135
[4]   THE HYPOTENSIVE ACTION OF MECAMYLAMINE [J].
DOYLE, AE ;
MURPHY, EA ;
NEILSON, GH .
BMJ-BRITISH MEDICAL JOURNAL, 1956, 2 (NOV24) :1209-1211
[5]   PHARMACOLOGY OF MECAMYLAMINE [J].
FORD, RV ;
MADISON, JC ;
MOYER, JH .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1956, 232 (02) :129-143
[6]  
FREIS ED, 1955, LANCET, V2, P977
[7]  
HARINGTON M, 1953, CLIN SCI, V12, P185
[8]  
McMICHAEL J, 1955, J Chronic Dis, V1, P527, DOI 10.1016/0021-9681(55)90064-3
[9]  
MCQUEEN E G, 1956, Postgrad Med J, V32, P85
[10]   USE OF MECAMYLAMINE IN THE MANAGEMENT OF HYPERTENSION [J].
SMIRK, FH ;
MCQUEEN, EG .
BRITISH MEDICAL JOURNAL, 1957, 1 (FEB23) :422-425